Stay updated on Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The record presents details of the completed Phase 3 KEYNOTE-412 study comparing pembrolizumab plus chemoradiation with placebo plus chemoradiation for locally advanced head and neck squamous cell carcinoma. It also provides trial results, eligibility requirements, participating locations, publications, and study documents.
    Difference
    100%
    Check dated 2026-11-08T01:16:41.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer now identifies site revision v3.8.0 instead of v3.7.2; the study record remains unavailable behind a 403 Forbidden response.
    Difference
    0.2%
    Check dated 2026-10-31T19:30:17.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH updates and says that “Super Intelligence” will be used in place of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-24T22:31:26.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:30:41.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-10T22:24:16.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with the standard site chrome; access to the study record is blocked rather than updated content, reflecting an access restriction rather than a page change.
    Difference
    0.5%
    Check dated 2026-09-26T22:07:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.